CTVA vs STRO
Corteva Inc (CTVA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CTVA and STRO stock pages for the full models.
Not investment advice.